Scientists at Oak Ridge National Laboratory have developed a first-ever method of detecting ribonucleic acid, or RNA, inside ...

FDA Approves EGRIFTA WR (Tesamorelin F8) to Treat Excess Visceral Abdominal Fat in Adults with HIV and LipodystrophyTotal Revenue $19 million, representing +17% growth year over yearFDA Approves Prior ...

Avidity Biosciences (RNA) announced the completion of enrollment in the biomarker cohort in the Phase 1/2 Fortitude clinical trial of delpacibart braxlosiran in people living with ...

The U.S. Food and Drug Administration on Friday approved Sanofi SA’s (NASDAQ:SNY) Qfitlia (fitusiran), the first antithrombin-lowering (AT) therapy for routine prophylaxis to prevent or reduce ...

Qfitlia uses small-interfering RNA technology, which enables low treatment frequency, subcutaneous dosing, and low volume injections.

Lucks is being inducted into the AAAS “for distinguished contributions to RNA biology and synthetic biology, particularly for discovering RNA folding principles important for understanding biology and ...

Chancellor Rachel Reeves delivered the spring statement on Wednesday, giving an update on the UK economy. In her announcement in the House of Commons, Reeves said that the government's "task is to ...

OpenAI is making it easier to edit images in ChatGPT and create visuals for work that include lengthy, legible text, potentially broadening the chatbot’s appeal for businesses and everyday users ...

SINGAPORE – A new programme has been launched in Singapore to formally study the applications of ribonucleic acid (RNA) in vaccine development, as well as in disease therapy and prevention ...

The February 2025 interval dates included 1/27/2025 through 2/23/2025. Nielsen reporting follows the broadcast calendar, and measurement weeks run Monday through Sunday. YouTube has exhibited steady ...

As Congress gears up to pass President Trump’s massive legislative package, one of the biggest fights is over the future of Medicaid. To make their targeted budget numbers, Republicans will ...